Guggenheim Capital’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Guggenheim Capital’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8,614	Closed	-$400K	–	1951
2023 Q2	$400K	Buy	+8,614	New	+$298K	﹤0.01%	1560

Guggenheim Capital's DICE Position: Q3 2023 in Review

Guggenheim Capital sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 8,614 shares — an estimated $400K sold.

Guggenheim Capital first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $400K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Guggenheim Capital reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Guggenheim Capital sold 8,614 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $400K.
Guggenheim Capital first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Guggenheim Capital's DICE Therapeutics, Inc. Common Stock position peaked at $400K in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Guggenheim Capital's 13F filing for Q3 2023, filed 14 Nov 2023.